Last reviewed · How we verify

NCT05543018

Effect of Intraocular Tamponade on Visual Perception

Status unknown NA Last updated 16 September 2022
What this trial tests

NA trial testing Electroretinogram in Retinal Detachment in 60 participants. Status unknown.

Timeline
12 September 2022
Primary endpoint
30 September 2023
28 October 2023

Quick facts

Lead sponsorBenha University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date12 September 2022
Primary completion30 September 2023
Estimated completion28 October 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

Adults 18 to 70, any sex, with Retinal Detachment or Optic Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intraocular tamponade used in vitrectomy operations may affects retinal function in various mechanisms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Electroretinogram

Trials testing the same drug.

Other recruiting trials for Retinal Detachment

Currently open trials in the same condition.

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05543018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing